Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy.

Cancers (Basel) · 2022 · PMC8909108 · PMID 35267634

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a near-significant trendp = 0.09so close (0.05 < p ≤ 0.1)

after ICI initiation, although we observed a near-significant trend for cancer type ( p = 0.09), with NSCLC accounting for more than 60% of cases receiving antibiotics post-ICI initiation ( Supplementary Table S3 ). 3.2.

also in 290 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.